Abstract
Dear Editor, The report on “Pityriasis rosea (PR) in chronic hepatitis C” is very interesting (1). Guner et al. (1) noted that this is “the first case of PR found in a patient with chronic hepatitis C while receiving Pegylated interferon (PEG-IFN) alpha 2b and ribavirin.” In fact, the cause of the existence of PR in hepatitis C is an interesting issue. Recurrence of hepatitis C following existence of PR is possible (2). The PR is mentioned because of its association with reactivation of human herpesvirus-6 (3) and human herpesvirus-6 can increase the severity of clinical features of hepatitis C infection (4). In the present case, whether PR previously existed or not is still inconclusive. Finally, it should be noted that there is at least one previous report on PR in a chronic hepatitis C patient receiving PEG-IFN alpha 2b and ribavirin (2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
